Novartis | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 350.71B 19.93B 2025-05
Amgen USD 150.93B 16.57B 2025-05
AstraZeneca GBP 166.72B 7.79B 2025-05
Bausch Health Companies CAD 2.62B 826.77M 2025-05
Biogen USD 17.99B 2.04B 2025-05
Bristol-Myers Squibb USD 101.53B 22.57B 2025-05
Canopy Growth CAD 612.33M 169.68M 2024-12
Corcept Therapeutics USD 7.45B 4.6B 2025-05
Eli Lilly USD 782B 40.35B 2025-05
Gilead Sciences USD 128.54B 11.15B 2025-05
GlaxoSmithKline GBP 60.04B 311.52M 2025-05
Glaxosmithkline USD 69.83B 14.22B 2024-12
Indivior 904.38M 0 2025-05
J&J USD 373.47B 26.18B 2025-05
Merck USD 208.29B 17.59B 2025-05
Novartis CHF 194.25B 18.5B 2024-12
Pacira USD 1.17B 18M 2025-05
Perrigo USD 3.48B 342M 2025-05
Pfizer USD 135.11B 8.61B 2025-05
Prestige Brands USD 4.33B 78M 2025-05
Sanofi EUR 120.97B 4.87B 2025-05
Supernus Pharmaceuticals USD 1.77B 244M 2025-05
Zoetis USD 68.6B 4.84B 2025-05



Novartis Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.